Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for Management of Breakthrough Pain

ClinicalTrials.gov ID: NCT00214942

Public ClinicalTrials.gov record NCT00214942. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 8:00 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for Management of Breakthrough Pain in Opioid-Tolerant Patients With Chronic Low Back Pain

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for Management of Breakthrough Pain in Opioid-Tolerant Patients with Chronic Low Back Pain

Study identification

NCT ID
NCT00214942
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Cephalon
Industry
Enrollment
Not listed

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2005 (Type not available)
Primary completion
Mar 2006 (Actual)
Completion
Not listed
Last update posted
May 9, 2014

Started 2005

United States locations

U.S. sites
17
U.S. states
11
U.S. cities
16
Facility City State ZIP Site status
Clopton Clinic Jonesboro Arkansas 72401 —
Vertex Clinical Research, Inc. Bakersfield California 93311 —
San Diego Arthritis Medical San Diego California 92106 —
Clinical Research of W Florida Clearwater Florida 33765 —
Florida Institute of Medical R Jacksonville Florida 32207 —
Clinical Pharmacology Services Tampa Florida 33617 —
Gold Coast Research Weston Florida 33331 —
Center for Prospective Outcome Marietta Georgia 30060 —
Georgia Medical Research Marietta Georgia 30060 —
American Medical Research Chicago Illinois 60616 —
American Medical Research Oak Brook Illinois 60523 —
American Medical Research Valparaiso Indiana 46383 —
Iowa Pain Management Clinic, P Des Moines Iowa 50265 —
Mid America Physiatrists, PA Overland Park Kansas 66211 —
Best Clinical Trial, Inc. New Orleans Louisiana 70115 —
PharmQuest Greensboro North Carolina 27401 —
Northwest Clinical Research Bellevue Washington 98004 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00214942, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 9, 2014 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00214942 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →